ROME IV FGIDs | Chapter 12: Centrally Mediated Disorders of Gastrointestinal Pain

ROME IV FGIDs | Chapter 11: Bowel Disorders

ROME IV FGIDs | Chapter 13: Gallbladder and Sphincter of Oddi Disorders

Clouse RE, Mayer EA, Aziz Q, et al. Functional abdominal pain syndrome. Gastroenterology 2006;130:1492-7.
Drossman DA. Chronic functional abdominal pain. The American journal of gastroenterology 1996;91:2270-81.
Zuckerman MJ, Guerra LG, Drossman DA, et al. Health-care-seeking behaviors related to bowel complaints. Hispanics versus non-Hispanic whites. Digestive diseases and sciences 1996;41:77-82.
Thompson W, Longstreth G, Drossman DA, Heaton K, Irvine EJ, Muller-Lissner S. . Functional bowel disorders and D. functional abdominal pain. In: Drossman DA CE, Talley NJ, Thompson WG, and Whitehead WE, eds, ed. Rome II: The Functional Gastrointestinal Disorders. Diagnosis, Pathohysiology and Treatment: A multinational Consensus. . Mclean, VA: Degnon Associates, 2000:351-432.
Issa B, Onon TS, Agrawal A, et al. Visceral hypersensitivity in endometriosis: a new target for treatment? Gut 2012;61:367-72.
Longstreth GF. Irritable bowel syndrome and chronic pelvic pain. Obstet Gynecol Surv 1994;49:505-7.
Heitkemper MM, Jarrett M. Pattern of gastrointestinal and somatic symptoms across the menstrual cycle. Gastroenterology 1992;102:505-13.
Ball E, Khan KS, Meads C. Does pelvic venous congestion syndrome exist and can it be treated? Acta Obstet Gynecol Scand 2012;91:525-8.
Kaya S, Hermans L, Willems T, et al. Central sensitization in urogynecological chronic pelvic pain: a systematic literature review. Pain Physician 2013;16:291-308.
Engeler DS, Baranowski AP, Dinis-Oliveira P, et al. The 2013 EAU guidelines on chronic pelvic pain: is management of chronic pelvic pain a habit, a philosophy, or a science? 10 years of development. Eur Urol 2013;64:431-9.
Longstreth GF, Yao JF. Irritable bowel syndrome and surgery: a multivariable analysis. Gastroenterology 2004;126:1665-73.
Reimerink JJ, van der Laan MJ, Koelemay MJ, et al. Systematic review and meta-analysis of population-based mortality from ruptured abdominal aortic aneurysm. Br J Surg 2013;100:1405-13.
Greenbaum DS, Greenbaum RB, Joseph JG, et al. Chronic abdominal wall pain. Diagnostic validity and costs. Digestive diseases and sciences 1994;39:1935-41.
Costanza CD, Longstreth GF, Liu AL. Chronic abdominal wall pain: clinical features, health care costs, and long-term outcome. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2004;2:395-9.
Stacy J, Frawley H, Powell G, et al. Persistent pelvic pain: rising to the challenge. Aust N Z J Obstet Gynaecol 2012;52:502-7.
Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Digestive diseases and sciences 1993;38:1569-80.
Thompson WG, Irvine EJ, Pare P, et al. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Digestive diseases and sciences 2002;47:225-35.
Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: a population-based study. The American journal of gastroenterology 2002;97:2290-9.
Kwan AC-P, Bao TN, Chakkaphak S, et al. Validation of Rome II criteria for functional gastrointestinal disorders by factor analysis of symptoms in Asian patient sample. Journal of gastroenterology and hepatology 2003;18:796-802.
Bharucha AE, Camilleri M. Functional abdominal pain in the elderly. Gastroenterol Clin North Am 2001;30:517-29.
Maxton DG, Whorwell PJ. Use of medical resorce and attitudes to health care of patients with chronic abdominal pain. Br J Med Econ 1992;2:75-79.
Chiou C, Wilson A, Longstreth G, Wade S, Wong J, Barghout V, Frech F, Offman J. . The relationship between IBS abdominal pain/discomfort and indirect costs. American Journal of Gastroenterology 2002;122 (Suppl.) ed. :A-462.
Howell S, Poulton R, Caspi A, et al. Relationship between abdominal pain subgroups in the community and psychiatric diagnosis and personality. A birth cohort study. Journal of psychosomatic research 2003;55:179-87.
Croft P, Lewis M, Hannaford P. Is all chronic pain the same? A 25-year follow-up study. Pain 2003;105:309-17.
Nickel R, Egle UT, Schwab R. [Diagnostic subgroups and psychosocial characteristics in chronic non-malignant pain patients referred to an out-patient pain center]. Psychotherapie, Psychosomatik, medizinische Psychologie 2002;52:378-85.
Taxonomy ATFo. “Part III: Pain Terms, A Current List with Definitions and Notes on Usage” In: Bogduk HMaN, ed. Classification of Chronic Pain. Second Edition ed. Seattle: IASP Press, 1994:pp 209-214.
Mayer EA, Naliboff BD, Craig AD. Neuroimaging of the brain-gut axis: from basic understanding to treatment of functional GI disorders. Gastroenterology 2006;131:1925-42.
Craig AD. The sentient self. Brain structure & function 2010;214:563-77.
Tillisch K, Mayer EA, Labus JS. Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome. Gastroenterology 2011;140:91-100.
Van Oudenhove L, Vandenberghe J, Dupont P, et al. Abnormal regional brain activity during rest and (anticipated) gastric distension in functional dyspepsia and the role of anxiety: a H(2)(15)O-PET study. The American journal of gastroenterology 2010;105:913-24.
Van Oudenhove L, Vandenberghe J, Dupont P, et al. Regional brain activity in functional dyspepsia: a H(2)(15)O-PET study on the role of gastric sensitivity and abuse history. Gastroenterology 2010;139:36-47.
Wilder-Smith CH, Li X, Shen L, et al. Dysfunctional endogenous pain modulation in patients with functional dyspepsia. Neurogastroenterol Motil 2014;26:489-98.
Larsson MB, Tillisch K, Craig AD, et al. Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome. Gastroenterology 2012;142:463-472 e3.
Song GH, Venkatraman V, Ho KY, et al. Cortical effects of anticipation and endogenous modulation of visceral pain assessed by functional brain MRI in irritable bowel syndrome patients and healthy controls. Pain 2006;126:79-90.
Devor M. Neuropathic pain: what do we do with all these theories? Acta anaesthesiologica Scandinavica 2001;45:1121-7.
Sperber AD, Morris CB, Greemberg L, et al. Development of abdominal pain and IBS following gynecological surgery: a prospective, controlled study. Gastroenterology 2008;134:75-84.
Nozu T, Kudaira M. Altered rectal sensory response induced by balloon distention in patients with functional abdominal pain syndrome. BioPsychoSocial medicine 2009;3:13.
Nozu T, Okumura T. Visceral sensation and irritable bowel syndrome; with special reference to comparison with functional abdominal pain syndrome. Journal of gastroenterology and hepatology 2011;26 Suppl 3:122-7.
Bingel U, Tracey I. Imaging CNS modulation of pain in humans. Physiology 2008;23:371-80.
Mayer EA, Tillisch K. The brain-gut axis in abdominal pain syndromes. Annual review of medicine 2011;62:381-96.
Lariviere WR, Wilson SG, Laughlin TM, et al. Heritability of nociception. III. Genetic relationships among commonly used assays of nociception and hypersensitivity. Pain 2002;97:75-86.
Le Bars D, Chitour D, Clot AM. The encoding of thermal stimuli by diffuse noxious inhibitory controls (DNIC). Brain research 1981;230:394-9.
Edwards RR, Ness TJ, Weigent DA, et al. Individual differences in diffuse noxious inhibitory controls (DNIC): association with clinical variables. Pain 2003;106:427-37.
Wilder-Smith CH, Robert-Yap J. Abnormal endogenous pain modulation and somatic and visceral hypersensitivity in female patients with irritable bowel syndrome. World journal of gastroenterology : WJG 2007;13:3699-704.
Mason P. Contributions of the medullary raphe and ventromedial reticular region to pain modulation and other homeostatic functions. Annual review of neuroscience 2001;24:737-77.
Petrovic P, Ingvar M. Imaging cognitive modulation of pain processing. Pain 2002;95:1-5.
Lieberman MD, Jarcho JM, Berman S, et al. The neural correlates of placebo effects: a disruption account. NeuroImage 2004;22:447-55.
Grupe DW, Nitschke JB. Uncertainty and anticipation in anxiety: an integrated neurobiological and psychological perspective. Nature reviews. Neuroscience 2013;14:488-501.
Ringel Y, Drossman DA, Turkington TG, et al. Regional brain activation in response to rectal distension in patients with irritable bowel syndrome and the effect of a history of abuse. Dig Dis Sci 2003;48:1774-81.
Ossipov MH, Dussor GO, Porreca F. Central modulation of pain. The Journal of clinical investigation 2010;120:3779-87.
Seminowicz DA, Mayberg HS, McIntosh AR, et al. Limbic-frontal circuitry in major depression: a path modeling metanalysis. NeuroImage 2004;22:409-18.
Elsenbruch S, Rosenberger C, Bingel U, et al. Patients with irritable bowel syndrome have altered emotional modulation of neural responses to visceral stimuli. Gastroenterology 2010;139:1310-9.
Jiang Z, Dinov ID, Labus J, et al. Sex-related differences of cortical thickness in patients with chronic abdominal pain. PloS one 2013;8:e73932.
Labus JS, Dinov ID, Jiang Z, et al. Irritable bowel syndrome in female patients is associated with alterations in structural brain networks. Pain 2014;155:137-49.
Zeng F, Qin W, Yang Y, et al. Regional brain structural abnormality in meal-related functional dyspepsia patients: a voxel-based morphometry study. PloS one 2013;8:e68383.
Ellingson BM, Mayer E, Harris RJ, et al. Diffusion tensor imaging detects microstructural reorganization in the brain associated with chronic irritable bowel syndrome. Pain 2013;154:1528-41.
Zhou G, Qin W, Zeng F, et al. White-matter microstructural changes in functional dyspepsia: a diffusion tensor imaging study. The American journal of gastroenterology 2013;108:260-9.
Mansour AR, Baliki MN, Huang L, et al. Brain white matter structural properties predict transition to chronic pain. Pain 2013;154:2160-8.
Seminowicz DA, Wideman TH, Naso L, et al. Effective treatment of chronic low back pain in humans reverses abnormal brain anatomy and function. The Journal of neuroscience : the official journal of the Society for Neuroscience 2011;31:7540-50.
Lee M, Tracey I. Neuro-genetics of persistent pain. Current opinion in neurobiology 2013;23:127-32.
Bashashati M, Rezaei N, Bashashati H, et al. Cytokine gene polymorphisms are associated with irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 2012;24:1102-e566.
Camilleri M. Genetics of human gastrointestinal sensation. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 2013;25:458-66.
Jones GT, Power C, Macfarlane GJ. Adverse events in childhood and chronic widespread pain in adult life: Results from the 1958 British Birth Cohort Study. Pain 2009;143:92-6.
Mayer EA, Derbyshire S, Naliboff BD. Cerebral activation in irritable bowel syndrome. Gastroenterology 2000;119:1418-20.
Wouters MM, Van Wanrooy S, Casteels C, et al. Altered brain activation to colorectal distention in visceral hypersensitive maternal-separated rats. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 2012;24:678-85, e297.
Barreau F, Ferrier L, Fioramonti J, et al. New insights in the etiology and pathophysiology of irritable bowel syndrome: contribution of neonatal stress models. Pediatric research 2007;62:240-5.
Mayer EA, Collins SM. Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology 2002;122:2032-48.
Ringel Y, Drossman DA, Leserman JL, et al. Effect of abuse history on pain reports and brain responses to aversive visceral stimulation: an FMRI study. Gastroenterology 2008;134:396-404.
Shelby GD, Shirkey KC, Sherman AL, et al. Functional abdominal pain in childhood and long-term vulnerability to anxiety disorders. Pediatrics 2013;132:475-82.
Walter SA, Jones MP, Talley NJ, et al. Abdominal pain is associated with anxiety and depression scores in a sample of the general adult population with no signs of organic gastrointestinal disease. Neurogastroenterol Motil 2013;25:741-e576.
Moeller-Bertram T, Afari N, Mostoufi S, et al. Specific Pain Complaints in Iraq and Afghanistan Veterans Screening Positive for Post-Traumatic Stress Disorder. Psychosomatics 2013.
Cheng C, Chan AO, Hui WM, et al. Coping strategies, illness perception, anxiety and depression of patients with idiopathic constipation: a population-based study. Aliment Pharmacol Ther 2003;18:319-26.
Cheng C, Hui W, Lam S. Perceptual style and behavioral pattern of individuals with functional gastrointestinal disorders. Health Psychol 2000;19:146-54.
Kendall-Tackett KA. Physiological correlates of childhood abuse: chronic hyperarousal in PTSD, depression, and irritable bowel syndrome. Child Abuse Negl 2000;24:799-810.
Danese A, McEwen BS. Adverse childhood experiences, allostasis, allostatic load, and age-related disease. Physiol Behav 2012;106:29-39.
Korte SM, Koolhaas JM, Wingfield JC, et al. The Darwinian concept of stress: benefits of allostasis and costs of allostatic load and the trade-offs in health and disease. Neurosci Biobehav Rev 2005;29:3-38.
Irwin C, Falsetti SA, Lydiard RB, et al. Comorbidity of Postraumatic Stress Disorder and Irritable Bowel Syndrome. Journal of Clinical Psychiatry 1996;57:576--581.
Cohen H, Jotkowitz A, Buskila D, et al. Post-traumatic stress disorder and other co-morbidities in a sample population of patients with irritable bowel syndrome. Eur J Intern Med 2006;17:567-71.
Fishbain DA, Bruns D, Meyer LJ, et al. Exploration of affirmation of childhood molestation (sexual abuse) in chronic pain patients, acute pain patients, community patients with pain and community nonpatients without pain. Pain Pract 2014;14:515-25.
Noll-Hussong M, Otti A, Laeer L, et al. Aftermath of sexual abuse history on adult patients suffering from chronic functional pain syndromes: an fMRI pilot study. J Psychosom Res 2010;68:483-7.
Bailey BE, Freedenfeld RN, Kiser RS, et al. Lifetime physical and sexual abuse in chronic pain patients: psychosocial correlates and treatment outcomes. Disabil Rehabil 2003;25:331-42.
Hart-Johnson T, Green CR. The impact of sexual or physical abuse history on pain-related outcomes among blacks and whites with chronic pain: gender influence. Pain Med 2012;13:229-42.
Drossman DA, Leserman J, Hu JB. Gastrointestinal diagnosis, abuse history, and effects on health status. Gastroenterology 1996;111:1159-61.
Drossman DA. Abuse, trauma, and GI illness: is there a link? Am J Gastroenterol 2011;106:14-25.
Morasco BJ, Lovejoy TI, Lu M, et al. The relationship between PTSD and chronic pain: mediating role of coping strategies and depression. Pain 2013;154:609-16.
Hillila MT, Hamalainen J, Heikkinen ME, et al. Gastrointestinal complaints among subjects with depressive symptoms in the general population. Aliment Pharmacol Ther 2008;28:648-54.
Bouchoucha M, Hejnar M, Devroede G, et al. Anxiety and depression as markers of multiplicity of sites of functional gastrointestinal disorders: A gender issue? Clin Res Hepatol Gastroenterol 2013;37:422-30.
Lackner JM, Gurtman MB. Patterns of interpersonal problems in irritable bowel syndrome patients: a circumplex analysis. J Psychosom Res 2005;58:523-32.
Smith MT, Edwards RR, Robinson RC, et al. Suicidal ideation, plans, and attempts in chronic pain patients: factors associated with increased risk. Pain 2004;111:201-8.
Spiegel B, Schoenfeld P, Naliboff B. Systematic review: the prevalence of suicidal behaviour in patients with chronic abdominal pain and irritable bowel syndrome. Aliment Pharmacol Ther 2007;26:183-93.
Racine M, Choiniere M, Nielson WR. Predictors of suicidal ideation in chronic pain patients: an exploratory study. Clin J Pain 2014;30:371-8.
Dimsdale JE, Creed F, Escobar J, et al. Somatic Symptom Disorder: An important change in DSM. J Psychosom Res 2013;75:223-8.
Duddu V, Isaac MK, Chaturvedi SK. Somatization, somatosensory amplification, attribution styles and illness behaviour: a review. Int Rev Psychiatry 2006;18:25-33.
Fishbain DA, Lewis JE, Gao J, et al. Is chronic pain associated with somatization/hypochondriasis? An evidence-based structured review. Pain Pract 2009;9:449-67.
Riedl A, Schmidtmann M, Stengel A, et al. Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J Psychosom Res 2008;64:573-82.
Lilly MM, Hong Phylice Lim B. Shared pathogeneses of posttrauma pathologies: attachment, emotion regulation, and cognitions. J Clin Psychol 2013;69:737-48.
Spitzer C, Barnow S, Gau K, et al. Childhood maltreatment in patients with somatization disorder. Aust N Z J Psychiatry 2008;42:335-41.
Landa A, Bossis AP, Boylan LS, et al. Beyond the unexplainable pain: relational world of patients with somatization syndromes. J Nerv Ment Dis 2012;200:413-22.
Mattila AK, Kronholm E, Jula A, et al. Alexithymia and somatization in general population. Psychosom Med 2008;70:716-22.
Spiegel BM, Kanwal F, Naliboff B, et al. The impact of somatization on the use of gastrointestinal health-care resources in patients with irritable bowel syndrome. Am J Gastroenterol 2005;100:2262-73.
Tomenson B, Essau C, Jacobi F, et al. Total somatic symptom score as a predictor of health outcome in somatic symptom disorders. Br J Psychiatry 2013;203:373-80.
Porcelli P, Todarello O. Psychological factors in medical disorders assessed with the diagnostic criteria for psychosomatic research. Adv Psychosom Med 2012;32:108-17.
Agosti V, Quitkin FM, Stewart JW, et al. Somatization as a predictor of medication discontinuation due to adverse events. Int Clin Psychopharmacol 2002;17:311-4.
Creed F. The outcome of medically unexplained symptoms--will DSM-V improve on DSM-IV somatoform disorders? J Psychosom Res 2009;66:379-81.
Labus JS, Mayer EA, Chang L, et al. The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index. Psychosom Med 2007;69:89-98.
Crombez G, Viane I, Eccleston C, et al. Attention to pain and fear of pain in patients with chronic pain. J Behav Med 2013;36:371-8.
Drossman DA, Leserman J, Li Z, et al. Effects of coping on health outcome among women with gastrointestinal disorders. Psychosom Med 2000;62:309-17.
Lackner JM, Gurtman MB. Pain catastrophizing and interpersonal problems: a circumplex analysis of the communal coping model. Pain 2004;110:597-604.
Piche M, Bouin M, Arsenault M, et al. Decreased pain inhibition in irritable bowel syndrome depends on altered descending modulation and higher-order brain processes. Neuroscience 2011;195:166-75.
Martel MO, Wasan AD, Jamison RN, et al. Catastrophic thinking and increased risk for prescription opioid misuse in patients with chronic pain. Drug Alcohol Depend 2013;132:335-41.
Kano M, Hamaguchi T, Itoh M, et al. Correlation between alexithymia and hypersensitivity to visceral stimulation in human. Pain 2007;132:252-63.
Yamada T, Inadomi JM, Bhattacharya R, et al. Approach to the patient with abdominal pain. In: Yamada T, ed. Yamada’s handbook of gastroenterology. 3rd Edition ed. Philadelphia: Wiley-Blackwell, 2013:58-69.
Drossman DA. Functional abdominal pain syndrome. Clin Gastroenterol Hepatol 2004;2:353-65.
Adler RH, Zamboni P, Hofer T, et al. How not to miss a somatic needle in the haystack of chronic pain. J Psychosom Res 1997;42:499-505.
Drossman DA. Patients with psychogenic abdominal pain: six years’ observation in the medical setting. The American journal of psychiatry 1982;139:1549-57.
Drossman DA. Diagnosing and treating patients with refractory functional gastrointestinal disorders. Annals of internal medicine 1995;123:688-97.
Hislop IG. Childhood deprivation: an antecedent of the irritable bowel syndrome. Med J Aust 1979;1:372-4.
Drossman DA, Talley NJ, Leserman J, et al. Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med 1995;123:782-94.
Leserman J, Drossman DA, Li Z, et al. Sexual and physical abuse history in gastroenterology practice: how types of abuse impact health status. Psychosom Med 1996;58:4-15.
Grover M, Drossman DA. Functional abdominal pain. Curr Gastroenterol Rep 2010;12:391-8.
Weiner BK. Difficult medical problems: on explanatory models and a pragmatic alternative. Med Hypotheses 2007;68:474-9.
Drossman DA. Challenges in the physician-patient relationship: feeling “drained”. Gastroenterology 2001;121:1037-8.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-13.
Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002;64:258-66.
Kroenke K, Spitzer RL, Williams JB, et al. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics 2009;50:613-21.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.
Drossman D, Corazziari E, Delvaux M, Spiller RC, Talley NJ, Thompson WG, Whitehead WE. Rome III: The Functional Gastrointestinal Disorders. McLean, VA: Degnon Associates, Inc., 2006.
Toner BB. Cognitive-behavioral treatment of irritable bowel syndrome. CNS Spectr 2005;10:883-90.
Berkman LF, Syme SL. Social networks, host resistance, and mortality: a nine-year follow-up study of Alameda County residents. Am J Epidemiol 1979;109:186-204.
Khan S, Chang L. Diagnosis and management of IBS. Nat Rev Gastroenterol Hepatol 2010;7:565-81.
Longstreth GF. Irritable bowel syndrome. Diagnosis in the managed care era. Dig Dis Sci 1997;42:1105-11.
DeVaul RA, Faillace LA. Persistent pain and illness insistence - A medical profile of proneness to surgery. Am J Surg 1978;135:828-833.
Gray DW, Dixon JM, Collin J. The closed eyes sign: an aid to diagnosing non-specific abdominal pain. BMJ 1988;297:837.
Dixon JM, Elton RA, Rainey JB, et al. Rectal examination in patients with pain in the right lower quadrant of the abdomen. BMJ 1991;302:386-8.
Chervu A, Clagett GP, Valentine RJ, et al. Role of physical examination in detection of abdominal aortic aneurysms. Surgery 1995;117:454-7.
McGarrity TJ, Peters DJ, Thompson C, et al. Outcome of patients with chronic abdominal pain referred to chronic pain clinic. Am J Gastroenterol 2000;95:1812-6.
Carnett J. Intercostal neuralgia as a cause of abdominal pain and tenderness. Surg Gynecol Obstet 1926;42:8.
Alfven G. Preliminary findings on increased muscle tension and tenderness, and recurrent abdominal pain in children. A clinical study. Acta Paediatr 1993;82:400-3.
Thomson WH, Dawes RF, Carter SS. Abdominal wall tenderness: a useful sign in chronic abdominal pain. Br J Surg 1991;78:223-5.
Akhnikh S, de Korte N, de Winter P. Anterior cutaneous nerve entrapment syndrome (ACNES): the forgotten diagnosis. Eur J Pediatr 2014;173:445-9.
van Assen T, de Jager-Kievit JW, Scheltinga MR, et al. Chronic abdominal wall pain misdiagnosed as functional abdominal pain. J Am Board Fam Med 2013;26:738-44.
van Assen T, Boelens OB, Kamphuis JT, et al. Construction and validation of a questionnaire distinguishing a chronic abdominal wall pain syndrome from irritable bowel syndrome. Frontline Gastroenterol 2012;3:288-294.
Meyer UA, Schuurmans MM, Lindberg RL. Acute porphyrias: pathogenesis of neurological manifestations. Semin Liver Dis 1998;18:43-52.
Lahr CJ, Griffith J, Subramony C, et al. Gastric electrical stimulation for abdominal pain in patients with symptoms of gastroparesis. Am Surg 2013;79:457-64.
Camdessanche JP, Antoine JC, Honnorat J, et al. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients. Brain 2002;125:166-75.
Whitcomb DC, Martin SP, Schoen RE, et al. Chronic abdominal pain caused by thoracic disc herniation. Am J Gastroenterol 1995;90:835-7.
Stormer S, Gerner HJ, Gruninger W, et al. Chronic pain/dysaesthesiae in spinal cord injury patients: results of a multicentre study. Spinal cord 1997;35:446-55.
Vanner SJ, Depew WT, Paterson WG, et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastroenterol 1999;94:2912-7.
Sperber AD, Drossman DA. Functional abdominal pain syndrome: Constant or frequently recurring abdominal pain. Am J Gastoenterology 2010;105:770-774.
Begtrup LM, Engsbro AL, Kjeldsen J, et al. A positive diagnostic strategy is noninferior to a strategy of exclusion for patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2013;11:956-62 e1.
Chey WD, Nojkov B, Rubenstein JH, et al. The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial. Am J Gastroenterol 2010;105:859-65.
Spiegel BM, Gralnek IM, Bolus R, et al. Is a negative colonoscopy associated with reassurance or improved health-related quality of life in irritable bowel syndrome? Gastrointest Endosc 2005;62:892-9.
Silva JA, White CJ. Ischemic bowel syndromes. Prim Care 2013;40:153-67.
Bobadilla JL. Mesenteric ischemia. Surg Clin North Am 2013;93:925-40, ix.
Youngster M, Laufer MR, Divasta AD. Endometriosis for the primary care physician. Curr Opin Pediatr 2013;25:454-62.
Srinivasan R, Greenbaum DS. Chronic abdominal wall pain: a frequently overlooked problem. Practical approach to diagnosis and management. Am J Gastroenterol 2002;97:824-30.
Boelens OB, Scheltinga MR, Houterman S, et al. Randomized clinical trial of trigger point infiltration with lidocaine to diagnose anterior cutaneous nerve entrapment syndrome. Br J Surg 2013;100:217-21.
Drossman DA. 2012 David Sun Lecture: Helping your patient by helping yourself: How to improve the patient-physician relationship by optimizing communication skills. American Journal of Gastroenterology 2013:521-528.
Drossman DA. Beyond tricyclics: new ideas for treating patients with painful and refractory functional gastrointestinal symptoms. Am J Gastroenterol 2009;104:2897-902.
Sperber AD, Drossman DA. Review article: The functional abdominal pain syndrome. Alimentary Pharmacology and Therapeutics 2011;33:514-524.
Dekel R, Drossman DA, Sperber AD. The use of psychotropic drugs in irritable bowel syndrome. Expert.Opin.Investig.Drugs 2013;22:329-339.
Roter DL, Hall JA. Doctors talking with patients/ Patients talking with doctors: Improving communication in medical visits. Westport, CT: Greenwood Publishing Group, 1992.
Longstreth GF, Drossman DA. Severe Irritable Bowel And Functional Abdominal Pain Syndromes: Managing The Patient And Health Care Costs. Clinical Gastroenterology and Hepatology 2005;3:397-400.
Van Dulmen AM, Fennis JF, Mokkink HG, et al. Doctor-dependent changes in complaint-related cognitions and anxiety during medical consultations in functional abdominal complaints. Psychol Med 1995;25:1011-8.
Conte HR, Plutchik R, Wild KV, et al. Combined psychotherapy and pharmacotherapy for depression: A systematic analysis of the evidence. Arch Gen Psychiatry 1986;43:471-479.
Drossman DA. Presidential Address: Gastrointestinal Illness and Biopsychosocial Model. Psychosom Med 1998;60:258-267.
Ford AC, Talley NJ, Schoenfeld PS, et al. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: Systematic review and meta-analysis. Gut 2009;58:367-378.
O’Malley PG, Jackson JL, Santoro J, et al. Antidepressant therapy for unexplained symptoms and symptom syndromes. The Journal of Family Practice 1999;48:980-990.
Fishbain DA, Cutler RB, Rosomoff HL, et al. Do antidepressants have an analgesic effect in psychogenic pain and somatoform pain disorder? A meta-analysis. Psychosom.Med 1998;60:503-509.
Drossman DA, Toner BB, Whitehead WE, et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 2003;125:19-31.
Perera TD, Park S, Nemirovskaya Y. Cognitive role of neurogenesis in depression and antidepressant treatment. Neuroscientist 2008;14:326-38.
Bremner JD. Does stress damage the brain? Biol Psychi 1999;45:797-805.
Konarski JZ, McIntyre RS, Kennedy SH, et al. Volumetric neuroimaging investigations in mood disorders: Bipolar disorder versus major depressive disorder. Bipolar.Disord. 2008;10:1-37.
Valet M, Gundel H, Sprenger T, et al. Patients with pain disorder show gray-matter loss in pain-processing structures: A voxel-based morphometric study. Psychosom Med 2009;71:49-56.
Blankstein U, Chen J, Diamant NE, et al. Altered brain structure in irritable bowel syndrome: Potential contributions of pre-existing and disease-driven factors. Gastroenterol 2010;138:1783-1789.
Han X, Tong J, Zhang J, et al. Imipramine treatment improves cognitive outcome associated with enhanced hippocampal neurogenesis after traumatic brain injury in mice. J.Neurotrauma 2011;28:995-1007.
Brunoni AR, Lopes M, Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: Implications for the role of neuroplasticity in depression. Int.J Neuropsychopharmacol. 2008;11:1169-1180.
Mic JA, Ardid D, Berrocoso E, et al. Antidepressants and pain. Trends in Pharmacological Sciences 2006;27:348-354.
Halpert A, Dalton C, B., Diamant NE, et al. Clinical response to tricyclic antidepressants in functional bowel disorders is not related to dosage. Am J Gastroenterol 2005;100:664-671.
Ruepert L, Quartero AO, de Wit NJ, et al. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane.Database.Syst.Rev. 2011:CD003460.
Rahimi R, Nikfar S, Rezaie A, et al. Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis. World J.Gastroenterol 2009;15:1548-1553.
Bomholt SF, Mikkelsen JD, Blackburn-Munro G. Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain. Neuropharmacology 2005;48:252-263.
Masand PS, Pae CU, Krulewicz S, et al. A double-blind, randomized, placebo-controlled trial of paroxetine controlled-release in irritable bowel syndrome. Psychosomatics 2009;50:78-86.
Kuiken SD, Tytgat GN, Boeckxstaens GE. The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study. Clin Gastroenterol Hepatol 2003;1:219-228.
Tack J, Broekaert D, Fischler B, et al. A controlled cross-over study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. Gut 2006;55:1095-1103.
Talley NJ, Kellow JE, Boyce P, et al. Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: A double-blind, randomized, placebo-controlled trial. Dig.Dis.Sci. 2008;53:108-115.
Locke GR, Bouras EP, Howden CW, et al. The Functional Dyspepsia Treatment Trial (Fdtt) Key Results. Gastroenterology 2013;144:S-140.
Gaynor PJ, Gopal M, Zheng W, et al. Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study. Curr.Med.Res.Opin. 2011;27:1859-1867.
Brennan BP, Fogarty KV, Roberts JL, et al. Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study. Hum.Psychopharmacol. 2009;24:423-428.
Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane.Database.Syst.Rev. 2007:CD005454.
Potvin S, Morin M, Cloutier C, et al. Add-on treatment of quetiapine for fibromyalgia: a pilot, randomized, double-blind, placebo-controlled 12-week trial. J Clin.Psychopharmacol. 2012;32:684-687.
Yost S, White J. Quetiapine for sleep. J.Pain Palliat.Care Pharmacother. 2010;24:53-55.
Fishbain DA, Cutler RB, Lewis J, et al. Do the second-generation “atypical neuroleptics” have analgesic properties? A structured evidence-based review. Pain Med 2004;5:359-365.
Grover M, Dorn SD, Weinland SR, et al. Atypical antipsychotic Quetiapine in the management of severe, refractory functional gastrointestinal disorders. Dig Dis Sci 2009;54:1284-1291.
Freedenfeld RN, Murray M, Fuchs PN, et al. Decreased pain and improved quality of life in fibromyalgia patients treated with olanzapine, an atypical neuroleptic. Pain Pract. 2006;6:112-118.
Martin-Blanco A, Pascual JC, Soler J, et al. Quetiapine in the treatment of refractory irritable bowel syndrome: a case report. Prog.Neuropsychopharmacol.Biol.Psychiatry 2010;34:715-716.
Aderka IM, McLean CP, Huppert JD, et al. Fear, avoidance and physiological symptoms during cognitive-behavioral therapy for social anxiety disorder. Behav Res Ther 2013;51:352-8.
Trivedi MH, Fava M, Wisniewski SR, et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med 2006;354:1243-1252.
Rosoff H, John RS, Prager F. Flu, risks, and videotape: escalating fear and avoidance. Risk Anal 2012;32:729-43.
Gale JD, Houghton LA. Alpha 2 Delta (alpha(2)delta) Ligands, Gabapentin and Pregabalin: What is the Evidence for Potential Use of These Ligands in Irritable Bowel Syndrome. Front Pharmacol. 2011;2:28.
Houghton LA, Fell C, Whorwell PJ, et al. Effect of a second-generation alpha2delta ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome. Gut 2007;56:1218-1225.
Butler LD, Koopman C, Cordova MJ, et al. Psychological distress and pain significantly increase before death in metastatic breast cancer patients. Psychosom Med 2003;65:416-26.
Chang L, Drossman DA. Irritable bowel syndrome and related functional disorders. In: Mayer EA, Bushnell MC, eds. Functional pain syndromes: Presentation and pathophysiology. Seattle: IASP Press, 2009:87-120.
Harris RE, Napadow V, Huggins JP, et al. Pregabalin rectifies aberrant brain chemistry, connectivity, and functional response in chronic pain patients. Anesthesiol 2013;119:1453-1464.
Grunkemeier DMS, Cassara JE, Dalton CB, et al. The narcotic bowel syndrome: Clinical features, pathophysiology, and management. Clin Gastroenterol Hepatol 2007;5:1126-1139.
Baune BT, Caliskan S, Todder D. Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression. Hum.Psychopharmacol. 2007;22:1-9.
Rosenberg JM, Harrell C, Ristic H, et al. The effect of gabapentin on neuropathic pain. Clinical Journal of Pain 1997;13:251-255.
Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005;352:1112-1120.
Goldapple K, Segal Z, Garson C, et al. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch.Gen.Psychiatry 2004;61:34-41.
Katon W, Robinson P, Von Korff M, et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry 1996;53:924-932.
Keller MB, McCullough JP, Klein DN, et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000;342:1462-1470.
Thase ME, Greenhouse JB, Frank E, et al. Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry 1997;54:1009-1015.
Bacaltchuk J, Trefiglio RP, Oliveira IR, et al. Combination of antidepressants and psychological treatments for bulimia nervosa: a systematic review. Acta Psychiatr.Scand. 2000;101:256-264.
Holroyd KA, O’Donnell FJ, Stensland J, et al. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination. JAMA 2001;285:2208-2215.
Gatchel RJ, Rollings KH. Evidence-informed management of chronic low back pain with cognitive behavioral therapy. Spine J 2008;8:40-4.
Wegener ST, Castillo RC, Haythornthwaite J, et al. Psychological distress mediates the effect of pain on function. Pain 2011;152:1349-57.
Walter S, Leissner N, Jerg-Bretzke L, et al. Pain and emotional processing in psychological trauma. Psychiatr Danub 2010;22:465-70.
Leung L. Pain catastrophizing: an updated review. Indian J Psychol Med 2012;34:204-17.
Esteve R, Ramirez-Maestre C. Pain fear avoidance and pain acceptance: a cross-sectional study comparing their influence on adjustment to chronic pain across three samples of patients. Ann Behav Med 2013;46:169-80.
Vlaeyen JW, Linton SJ. Fear-avoidance model of chronic musculoskeletal pain: 12 years on. Pain 2012;153:1144-7.
Costa Lda C, Maher CG, McAuley JH, et al. Self-efficacy is more important than fear of movement in mediating the relationship between pain and disability in chronic low back pain. Eur J Pain 2011;15:213-9.
Saunders D. Coping with chronic pain: what can we learn from pain self-efficacy beliefs? J Rheumatol 2004;31:1032-4.
Muller L, Korsgaard H, Ethelberg S. Burden of acute gastrointestinal illness in Denmark 2009: a population-based telephone survey. Epidemiol Infect 2012;140:290-8.
McCracken LM, Eccleston C. Coping or acceptance: what to do about chronic pain? Pain 2003;105:197-204.
Lackner JM, Jaccard J, Krasner SS, et al. Self-administered cognitive behavior therapy for moderate to severe irritable bowel syndrome: clinical efficacy, tolerability, feasibility. Clin Gastroenterol Hepatol 2008;6:899-906.
Craske MG, Wolitzky-Taylor KB, Labus J, et al. A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations. Behav Res Ther 2011;49:413-21.
McCracken LM, MacKichan F, Eccleston C. Contextual cognitive-behavioral therapy for severely disabled chronic pain sufferers: effectiveness and clinically significant change. Eur J Pain 2007;11:314-22.
Raftery MN, Murphy AW, O’Shea E, et al. Effectiveness of a cognitive behavioural therapy-based rehabilitation programme (Progressive Goal Attainment Program) for patients who are work-disabled due to back pain: study protocol for a multicentre randomised controlled trial. Trials 2013;14:290.
Sveinsdottir V, Eriksen HR, Reme SE. Assessing the role of cognitive behavioral therapy in the management of chronic nonspecific back pain. J Pain Res 2012;5:371-80.
Jensen KB, Kosek E, Wicksell R, et al. Cognitive Behavioral Therapy increases pain-evoked activation of the prefrontal cortex in patients with fibromyalgia. Pain 2012;153:1495-503.
Lofrisco BM. Female sexual pain disorders and cognitive behavioral therapy. J Sex Res 2011;48:573-9.
Moseley GL. Widespread brain activity during an abdominal task markedly reduced after pain physiology education: fMRI evaluation of a single patient with chronic low back pain. Aust J Physiother 2005;51:49-52.
Kerns RD, Sellinger J, Goodin BR. Psychological treatment of chronic pain. Annu Rev Clin Psychol 2011;7:411-34.
Guthrie E, Creed F, Dawson D, et al. A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology 1991;100:450-7.
Creed F, Fernandes L, Guthrie E, et al. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology 2003;124:303-17.
Svedlund J, Sjodin I, Ottosson JO, et al. Controlled study of psychotherapy in irritable bowel syndrome. Lancet 1983;2:589-92.
Hamilton J, Guthrie E, Creed F, Thompson D, Tomenson B. . A randomized controlled trial of psychotherapy in chronic functional dyspepsia. Gastroenterology 2000;119:661-9.
Sattel H, Lahmann C, Gündel H, Guthrie E, Kruse J, Noll-Hussong M, Ohmann C, Ronel J, Sack M, Sauer N, Schneider G, Henningsen P. . Brief psychodynamic interpersonal psychotherapy for patients with multisomatoform disorder: randomised controlled trial. Br J Psychiatry 2012;200:60-7.
Guthrie EA, Creed FH, Whorwell PJ, et al. Outpatients with irritable bowel syndrome: a comparison of first time and chronic attenders. Gut 1992;33:361-3.
Bennett EJ, Tennant CC, Piesse C, et al. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut 1998;43:256-61.
Creed F, Guthrie E, Ratcliffe J, et al. Reported sexual abuse predicts impaired functioning but a good response to psychological treatments in patients with severe irritable bowel syndrome. Psychosom Med 2005;67:490-9.
Guthrie E, Barlow J. Fernandes L. Ratcliffe J. Read N. Thompson DG. Tomenson B. Creed F. North of England IBS Research Group. Changes in tolerance to rectal distension correlate with changes in psychological state in patients with severe irritable bowel syndrome. Psychosomatic Medicine 2004;66:578-82.
Hyphantis T, Guthrie E, Tomenson B, et al. Psychodynamic interpersonal therapy and improvement in interpersonal difficulties in people with severe irritable bowel syndrome. Pain 2009;145:196-203.
Miller V, Whorwell PJ. Hypnotherapy for functional gastrointestinal disorders: a review. Int J Clin Exp Hypn 2009;57:279-92.
Lindfors P, Ljotsson B, Bjornsson E, et al. Patient satisfaction after gut-directed hypnotherapy in irritable bowel syndrome. Neurogastroenterol Motil 2013;25:169-e86.
Moser G, Tragner S, Gajowniczek EE, et al. Long-term success of GUT-directed group hypnosis for patients with refractory irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol 2013;108:602-9.
Vlieger AM, Rutten JM, Govers AM, et al. Long-term follow-up of gut-directed hypnotherapy vs. standard care in children with functional abdominal pain or irritable bowel syndrome. Am J Gastroenterol 2012;107:627-31.
Gonsalkorale WM, Toner BB, Whorwell PJ. Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome. J Psychosom Res 2004;56:271-8.
Gonsalkorale WM, Houghton LA, Whorwell PJ. Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness. Am J Gastroenterol 2002;97:954-61.
Kabat-Zinn J. An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation: theoretical considerations and preliminary results. Gen Hosp Psychiatry 1982;4:33-47.
Cramer H, Haller H, Lauche R, et al. Mindfulness-based stress reduction for low back pain. A systematic review. BMC Complement Altern Med 2012;12:162.
Kilpatrick LA, Suyenobu BY, Smith SR, et al. Impact of Mindfulness-Based Stress Reduction training on intrinsic brain connectivity. Neuroimage 2011;56:290-8.
Veehof MM, Oskam MJ, Schreurs KM, et al. Acceptance-based interventions for the treatment of chronic pain: a systematic review and meta-analysis. Pain 2011;152:533-42.
Hayes SC, Levin ME, Plumb-Vilardaga J, et al. Acceptance and commitment therapy and contextual behavioral science: examining the progress of a distinctive model of behavioral and cognitive therapy. Behav Ther 2013;44:180-98.
McCracken LM, Carson JW, Eccleston C, et al. Acceptance and change in the context of chronic pain. Pain 2004;109:4-7.
McCracken LM, Velleman SC. Psychological flexibility in adults with chronic pain: a study of acceptance, mindfulness, and values-based action in primary care. Pain 2010;148:141-7.
Kashdan TB, Rottenberg J. Psychological flexibility as a fundamental aspect of health. Clin Psychol Rev 2010;30:865-78.
Lembo AJ, Conboy L, Kelley JM, et al. A treatment trial of acupuncture in IBS patients. Am J Gastroenterol 2009;104:1489-97.
Reynolds JA, Bland JM, MacPherson H. Acupuncture for irritable bowel syndrome an exploratory randomised controlled trial. Acupunct Med 2008;26:8-16.
MacPherson H, Tilbrook H, Bland JM, et al. Acupuncture for irritable bowel syndrome: primary care based pragmatic randomised controlled trial. BMC Gastroenterol 2012;12:150.
Schneider A, Enck P, Streitberger K, et al. Acupuncture treatment in irritable bowel syndrome. Gut 2006;55:649-54.
Forbes A, Jackson S, Walter C, et al. Acupuncture for irritable bowel syndrome: a blinded placebo-controlled trial. World J Gastroenterol 2005;11:4040-4.
Assendelft WJ, Morton SC, Yu EI, et al. Spinal manipulative therapy for low back pain. A meta-analysis of effectiveness relative to other therapies. Ann Intern Med 2003;138:871-81.
Assendelft WJ, Morton SC, Yu EI, et al. Spinal manipulative therapy for low back pain. Cochrane Database Syst Rev 2004:CD000447.
Ernst E. Manual therapies for pain control: chiropractic and massage. Clin J Pain 2004;20:8-12.
Furlan AD, Brosseau L, Welch V, et al. Massage for low back pain. Cochrane Database Syst Rev 2000:CD001929.
Sylvester K, Kendall GP, Lennard-Jones JE. Treatment of functional abdominal pain by transcutaneous electrical nerve stimulation. Br Med J (Clin Res Ed) 1986;293:481-2.
McQuay HJ, Moore RA, Eccleston C, et al. Systematic review of outpatient services for chronic pain control. Health Technol Assess 1997;1:i-iv, 1-135.
Shah RV, Ericksen JJ, Lacerte M. Interventions in chronic pain management. 2. New frontiers: invasive nonsurgical interventions. Arch Phys Med Rehabil 2003;84:S39-44.
Bogduk N. Diagnostic nerve blocks in chronic pain. Best Pract Res Clin Anaesthesiol 2002;16:565-78.
Garvey TA, Marks MR, Wiesel SW. A prospective, randomized, double-blind evaluation of trigger-point injection therapy for low-back pain. Spine (Phila Pa 1976) 1989;14:962-4.
Hastings RH, McKay WR. Treatment of benign chronic abdominal pain with neurolytic celiac plexus block. Anesthesiology 1991;75:156-8.
Onders RP, Mittendorf EA. Utility of laparoscopy in chronic abdominal pain. Surgery 2003;134:549-52; discussion 552-4.
Mueller MD, Tschudi J, Herrmann U, et al. An evaluation of laparoscopic adhesiolysis in patients with chronic abdominal pain. Surg Endosc 1995;9:802-4.
Di Lorenzo N, Coscarella G, Lirosi F, et al. [Impact of laparoscopic surgery in the treatment of chronic abdominal pain syndrome]. Chir Ital 2002;54:367-78.
Swank DJ, Swank-Bordewijk SC, Hop WC, et al. Laparoscopic adhesiolysis in patients with chronic abdominal pain: a blinded randomised controlled multi-centre trial. Lancet 2003;361:1247-51.
Sandgren JE, McPhee MS, Greenberger NJ. Narcotic bowel syndrome treated with Clonidine. Ann Intern Med 1984;101:331-334.
Rogers M, Cerda JJ. Editorial: The narcotic bowel syndrome. J Clin Gastroenterol 1989;11:132-135.
Drossman DA, Morris CB, Wrennall CE, et al. Diagnosis, characterization, and 3-month outcome after detoxification of 39 patients With Narcotic Bowel Syndrome. Am J Gastroenterol 2012;107:1426-1440.
Trescot AM, Boswell MV, Atluri SL, et al. Opioid guidelines in the management of chronic non-cancer pain. Pain Physician 2006;9:1-39.
Manchikanti L, Fellows B, Ailinani H, et al. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician 2010;13:401-435.
Berry PH, Dahl JL. The new JCAHO pain standards: implications for pain management nurses. Pain Manag.Nurs. 2000;1:3-12.
Grady D, Berkowitz SA, Katz MH. Opioids for chronic pain. Arch.Intern.Med. 2011;171:1426-1427.
Choung RS, Locke GR, III, Zinsmeister AR, et al. Opioid bowel dysfunction and narcotic bowel syndrome: A population-based study. Am.J.Gastroenterol. 2009;104:1199-1204.
Tuteja AK, Biskupiak J, Stoddard GJ, et al. Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain. Neurogastroenterol.Motil. 2010;22:424-e96.
Farmer AD, Ferdinand E, Aziz Q. Opioids and the gastrointestinal tract - a case of narcotic bowel syndrome and literature review. J Neurogastroenterol.Motil. 2013;19:94-98.
Pappagallo M. Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg. 2001;182:11S-18S.
Drossman DA, Webster LR, Becker G, et al. Unmet needs in opiod-induced constipation. unknown 2014.
Ford AC, Brenner DM, Schoenfeld PS. Efficacy of Pharmacological Therapies for the Treatment of Opioid-Induced Constipation: Systematic Review and Meta-Analysis. Am J Gastroenterol 2013;108:1566-1574.
Camilleri M. Opioid-induced constipation: Challenges and therapeutic opportunities. Am J Gastroenterol 2011;106:835-842.
Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain 2008;24:479-496.
Grover CA, Wiele ED, Close RJ. Narcotic bowel syndrome. J Emerg.Med 2012;43:992-995.
Watkins LR, Milligan ED, Maier SF. Glial activation: a driving force for pathological pain. Trends Neurosci. 2001;24:450-455.
Watkins LR, Hutchinson MR, Johnston IN, et al. Glia: novel counter-regulators of opioid analgesia. Trends Neurosci. 2005;28:661-669.
Hutchinson MR, Shavit Y, Grace PM, et al. Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia. Pharmacol.Rev. 2011;63:772-810.
Wang XM, Liu YL. Signal transduction pathway of colonic toll-like receptor 4 in patients with irritable bowel syndrome. Zhonghua Yi.Xue.Za Zhi. 2008;88:3415-3417.
Hutchinson MR, Loram LC, Zhang Y, et al. Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity. Neuroscience 2010;168:551-563.
Crain SM, Shen KF. Antagonists of excitatory opioid receptor functions enhance morphine’s analgesic potency and attenuate opioid tolerance/dependence liability. Pain 2000;84:121-131.
Porreca F, Ossipov MH, Gebhart GF. Chronic pain and medullary descending facilitation. Trends Neurosci. 2002;25:319-325.
Fields HL. Is there a facilitating component to central pain modulation? American Pain Society Journal 1992;1:71-78.
Agostini S, Eutamene H, Cartier C, et al. Evidence of central and peripheral sensitization in a rat model of narcotic bowel like-syndrome. Gastroenterol 2010;139:553-563.
Brabant M, Brissette S, Lauzon P, et al. [Opioid use disorder in patients with chronic non-cancer pain]. Sante Ment Que 2014;39:117-32.
Hasin DS, O’Brien CP, Auriacombe M, et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry 2013;170:834-51.
Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the Current Opioid Misuse Measure. Pain 2007;130:144-156.

You must be logged in with a subscription to access this page. Click here to login.